Aridis Pharmaceuticals's total assets for Q3 2023 were $6.53M, an increase of 0.80% from the previous quarter. ARDS total liabilities were $18.34M for the fiscal quarter, a -14.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.